跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-GLICLAZIDE MR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-GLICLAZIDE MR
Authorized
STANDARD
TARO-GLICLAZIDE MR
sun pharma canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bc8968b337a4fdf0
Company
sun pharma canada inc
Type
Standard
Approval Details
Approval Id
bc8968b337a4fdf0
Drug Approval Canada Name
TARO-GLICLAZIDE MR
Product Name
TARO-GLICLAZIDE MR
Status
Marketed
Status Date
2021-02-22
Original Market Date
2018-04-03
Din
02463571
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.20
Atc Original
A10BB09 GLICLAZIDE
Atc Name
a 10 bb 09
Aig Number
0119934002
Company Name
sun pharma canada inc
Company Address
126 East Drive, Brampton, Ontario, Canada, L6T 1C1
Active Ingredients
GLICLAZIDE
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bc8968b337a4fdf0
Type
Standard
Back to Health Canada Approvals